Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.7%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check66 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check81 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study criteria and descriptions related to GSK3511294 (Depemokimab) for asthma, while also updating the revision number from v2.14.4 to v2.15.0.SummaryDifference24%
Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.